C News 48.19 06/04/2014 04:32:08 Citigroup Inc (C)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Citigroup Inc (C) 48.19 $C

Arista Networks IPO Targets Cisco In Data Networking
at Investor's Business Daily - Tue Jun 03, 6:21PM CDT
Cloud computing has fundamentally changed the way companies build data centers and deliver software applications. Arista Networks (ANET), a leading provider of cloud networking solutions, is tapping into this enthusiasm with an initial public...

Final Glance: Banks companies
AP - Tue Jun 03, 5:01PM CDT
NEW YORK (AP) — Shares of some top banks companies were mixed at the close of trading:

Citigroup Announces Reference Yields and Total Consideration for Note Tender Offers
Business Wire - Tue Jun 03, 3:30PM CDT
Citigroup Inc. ("Citigroup" announced today the applicable Reference Yield and Total Consideration for the previously announced cash tender offers (each, an "Offer" and, collectively, the "Offers" with respect to each series of Notes listed in the table below (the "Notes".

Can These Stocks Outperform the Big Four Banks?
Matt Koppenheffer and David Hanson, The Motley Fool - Motley Fool - Tue Jun 03, 12:57PM CDT
JPMorgan Chase   ,  Bank of America   ,  Wells Fargo   , and  Citigroup   make up the big four banks. But can a new collection of bank stocks usurp their top rankings in the next decade?  With that in mind, Fool in the blank: A basket of...

Most active New York Stock Exchange-traded stocks
AP - Tue Jun 03, 12:31PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:

Midday Glance: Banks companies
AP - Tue Jun 03, 12:30PM CDT
NEW YORK (AP) — Shares of some top banks companies are mixed at 1 p.m.:

Early Glance: Banks companies
AP - Tue Jun 03, 10:20AM CDT
NEW YORK (AP) — Shares of some top banks companies are mixed at 10 a.m.:

Are Citigroup and Goldman Sachs Making a "Permanently" Bad Bet?
Matt Koppenheffer and David Hanson, The Motley Fool - Motley Fool - Tue Jun 03, 9:53AM CDT
Fixed income trading is in the dumps. Does that mean  Goldman Sachs    will never be a good bank again because it relies on fixed income, currencies, and commodities? Or perhaps with some banks  cutting back on FICC exposure, some opportunities...

Citigroup Announces Upsizing of Offers to Purchase Specified Series of Outstanding Notes
Business Wire - Tue Jun 03, 9:00AM CDT
Citigroup Inc. ("Citigroup" announced today that it has increased the maximum aggregate principal amount of specified series of notes (the "Notes" that it will accept (each, a "Maximum Series Tender Cap" pursuant to its previously announced cash tender offers (each, an "Offer" and, collectively, the "Offers", as set forth in the table below.

How Will PBF Logistics (PBFX) Stock Be Affected By This Coverage Initiation
at The Street - Tue Jun 03, 8:21AM CDT
PBF Logistics (PBFX) had coverage initiated by several firms on Tuesday.

The Suprising Way Banks Have Changed Since the Collapse of Lehman Brothers
Patrick Morris, The Motley Fool - Motley Fool - Tue Jun 03, 6:56AM CDT
Much has been said about the financial crisis and what it has meant for the biggest banks. But one little known fact could mean big things in the years to come. The unknown reality The research division at Bank of America recently revealed a...

'Mad Money' Lightning Round: Stay Away From Citigroup
at The Street - Tue Jun 03, 5:00AM CDT
Cramer says he's sticking with Baxter International but he's disappointed in Briggs & Stratton.

Jim Cramer's 'Mad Money' Recap: Individual Stocks Rule
at The Street - Mon Jun 02, 7:16PM CDT
Cramer sounds off against the professional money managers who trade the market like it's merely a basket of commodities.

JPMorgan Sued by LA Over Lending Practices - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 02, 4:40PM CDT
Legal predicaments continue to haunt JPMorgan (JPM). The bank has been sued by Los Angeles over its discriminatory lending practices.

Citigroup May Vend OneMain Financial - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 02, 4:25PM CDT
Citigroup Inc.'s (C) CEO Michael Corbat stated the possible sale of its consumer-lending business -- OneMain Financial at an investor conference on Thursday.

Citigroup (C) Crosses Pivot Point Resistance at $47.73
Comtex SmarTrend(R) - Mon Jun 02, 12:28PM CDT
Citigroup (NYSE:C) has opened bullishly above the pivot of $47.44 today and has reached the first level of resistance at $47.73. Investors may be interested in a cross of the next upside pivot targets of $47.89 and $48.34.

2 New Issues IPO Investors Need to Know About for This Week
Eric Volkman, The Motley Fool - Motley Fool - Sun Jun 01, 10:30AM CDT
Investors could be forgiven for thinking that the IPO market has fallen into a ditch and can't get out. Last week saw a grand total of zero new issues, while in the coming five days only a single new stock, Arista Networks , is scheduled to hit the...

Los Angeles sues JPMorgan Chase over foreclosures
AP - Fri May 30, 7:25PM CDT
LOS ANGELES (AP) — Los Angeles is suing JPMorgan Chase for mortgage discrimination that the city says led to a wave of foreclosures that blighted neighborhoods, reduced property taxes and increased the need for costly city services.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 36

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

AgEagle Aerial Systems Welcomes Kevin Lowdermilk to the Board

Updated Category News Views 103

AgEagle Aerial Systems Welcomes Kevin Lowdermilk to the Board AgEagle Aerial Systems Inc. (NYSE: UAVS), renowned for its top-tier unmanned aerial systems (UAS), is excited to announce the recent addition of Kevin Lowdermilk to its board of directors. His appointment, effective as of late October, marks a strategic enhancement to the company's leadership team, ensuring...

Continue Reading
Natera's Growth Continues Amid Legal Challenges and Market Wins

Updated Category News Views 413

Natera Faces Legal Challenges with Strong Market Performance Natera, Inc. (NASDAQ: NTRA) is a leader in the genetic testing industry, known for its groundbreaking contributions to oncology and women’s health. Recently, the company encountered an unfavorable jury decision in a legal battle concerning false advertising claims made against Guardant Health (NASDAQ: GH). The...

Continue Reading
Spreedly Sees Unprecedented Growth in Open Payments Sector

Updated Category News Views 110

Spreedly Surges Ahead in Open Payments Innovation Spreedly, a prominent leader in open payments, has recently showcased remarkable progress in revenue and customer expansion, marking a new chapter in the payment processing industry. With a growing clientele that spans across varied sectors, the company is redefining how digital transactions are handled worldwide. Key...

Continue Reading
Shelley Joyce Takes the Helm as CTO at TSG, Ramping Up Innovation

Updated Category News Views 431

TSG Appoints Shelley Joyce as New Chief Technology Officer In a significant move to enhance its technology initiatives, TSG (The Strawhecker Group) has announced the appointment of Shelley Joyce as the Chief Technology Officer (CTO). With her extensive background in the payments industry, Shelley is set to lead TSG’s technological advancements and cater to the evolving...

Continue Reading
Equillium Plans Engaging Event for Ulcerative Colitis Insights

Updated Category News Views 121

Equillium's Upcoming Event on Ulcerative Colitis Equillium, Inc. (NASDAQ: EQ), a biotechnology company focused on developing innovative therapeutics for autoimmune and inflammatory diseases, has announced an exciting virtual event featuring prominent thought leaders in the field of ulcerative colitis (UC). This event is scheduled for a Wednesday in November at 12 PM ET....

Continue Reading